Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 982
of 50Next
1:

Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.

Mody RM, Erwin DP, Summers AM, Carrero HA, Selby EB, Ewell AJ, Moran KA.

Ann Clin Microbiol Antimicrob. 2007 Jun 6;6:6.

PMID: 17553151 [PubMed - indexed for MEDLINE]

2:

In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.

Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.

Expert Opin Pharmacother. 2008 Jun;9(9):1441-9.

PMID: 18518776 [PubMed - indexed for MEDLINE]

3:

Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.

Moczygemba LR, Frei CR, Burgess DS.

Clin Ther. 2004 Nov;26(11):1800-7.

PMID: 15639692 [PubMed - indexed for MEDLINE]

5:

Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.

Hernández JR, Velasco C, Romero L, Martínez-Martínez L, Pascual A.

Int J Antimicrob Agents. 2006 Nov;28(5):457-9. Epub 2006 Sep 27.

PMID: 17008066 [PubMed - indexed for MEDLINE]

6:

Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.

DeRyke CA, Banevicius MA, Fan HW, Nicolau DP.

Antimicrob Agents Chemother. 2007 Apr;51(4):1481-6. Epub 2007 Feb 5.

PMID: 17283197 [PubMed - indexed for MEDLINE]

7:

Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.

Isr Med Assoc J. 2005 May;7(5):298-301.

PMID: 15909461 [PubMed - indexed for MEDLINE]

8:

Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.

Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A; Norwegian ESBL Study Group.

J Clin Microbiol. 2007 Jan;45(1):199-205. Epub 2006 Nov 1.

PMID: 17079502 [PubMed - indexed for MEDLINE]

9:

Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.

Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.

P R Health Sci J. 2004 Sep;23(3):207-15.

PMID: 15631176 [PubMed - indexed for MEDLINE]

10:

Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.

Kiffer CR, Kuti JL, Eagye KJ, Mendes C, Nicolau DP.

Int J Antimicrob Agents. 2006 Oct;28(4):340-4. Epub 2006 Aug 22.

PMID: 16930951 [PubMed - indexed for MEDLINE]

11:

Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.

Yang K, Guglielmo BJ.

Ann Pharmacother. 2007 Sep;41(9):1427-35. Epub 2007 Jul 31. Review.

PMID: 17666573 [PubMed - indexed for MEDLINE]

12:

Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.

Raveh D, Yinnon AM, Broide E, Rudensky B.

Chemotherapy. 2007;53(3):185-9. Epub 2007 Mar 7.

PMID: 17347564 [PubMed - indexed for MEDLINE]

13:

[Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]

Xiong Z, Zhu D, Zhang Y, Wang F.

Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1476-9. Chinese.

PMID: 12509910 [PubMed - indexed for MEDLINE]

14:

Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Duttaroy B, Mehta S.

Indian J Pathol Microbiol. 2005 Jan;48(1):45-8.

PMID: 16758790 [PubMed - indexed for MEDLINE]

15:

In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.

Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, Chen YC, Chang SC.

J Microbiol Immunol Infect. 2006 Feb;39(1):59-66.

PMID: 16440125 [PubMed - indexed for MEDLINE]

16:

[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]

Zarakolu P, Hasçelik G, Unal S.

Mikrobiyol Bul. 2006 Jul;40(3):147-54. Turkish.

PMID: 17001842 [PubMed - indexed for MEDLINE]

17:

Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.

Yu Y, Zhou W, Chen Y, Ding Y, Ma Y.

Chin Med J (Engl). 2002 Oct;115(10):1479-82.

PMID: 12490091 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 982
of 50Next